Latest News
Beta Bionics, Inc.
- Bronstein, Gewirtz & Grossman LLC Urges Beta Bionics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
- Beta Bionics, Inc. (BBNX) Stock Price Prediction for 2026, 2030-2040
- Beta bionics CCO Mark Hopman sells $13,446 in shares
- Senseonics Bets a No-Money Deal With Beta Bionics Can Pull It Out of a Niche
- Beta Bionics (BBNX) Faces Class Action After 37% Stock Drop
- Beta Bionics (BBNX) Faces Securities Fraud Class Action
- Beta Bionics (BBNX) Faces Securities Fraud Class Action
- Beta Bionics (BBNX) Hit by Class Action After 37% Stock Drop
- NASDAQ: BBNX INVESTOR ALERT: Berger Montague Advises Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a November 3, 2026 Deadline
- Robbins LLP Urges BBNX Stockholders to Contact the Firm for Information About the Class Action Against Beta Bionics, Inc.
- Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Headlines from the last 30 days, linking to the original publishers. See all market news →